MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Crushing valbenazine capsule contents for potential addition to soft foods or administration via G tube

M. Hebert, A. Mar, R. Moore, A. Bristow, S. Siegert (San Diego, USA)

Meeting: 2023 International Congress

Abstract Number: 9

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Treatment, Dysphagia, Tardive dyskinesia(TD)

Category: Clinical Trials and Therapy in Movement Disorders (non-PD) (non-Dystonia)

Objective: To evaluate the suitability of mixing crushed contents from valbenazine capsules with soft foods/liquids or adding them to water for delivery through a gastrostomy tube (G-tube).

Background: Once-daily valbenazine is FDA-approved for tardive dyskinesia, with potential additional indications for chorea associated with Huntington disease and dyskinetic cerebral palsy. Dysphagia can occur with these disorders, making it difficult to swallow whole medications.

Method: Three studies were conducted on two doses of valbenazine capsules (40 and 80 mg). In Study 1, whole valbenazine capsules and crushed capsule contents were dissolved in a warm solution. Samples were collected serially over 1 hour (from 10 to 60 min) for analysis. In Study 2, the crushed contents of valbenazine capsules (both doses) were mixed into applesauce, yogurt, and pudding; crushed contents (40 mg) were also added to buffer solutions (pH 1.2, 4.5, 6.8) and fed-state simulated gastric fluid (FeSSGF). In Study 3, crushed valbenazine capsule contents (both doses) were dispersed in tap water (approximately 0° to 50°C) and added to a G-tube via a syringe, with and without a cup rinse. In Studies 2 and 3, conditions that yielded 90-110% valbenazine recovery were considered acceptable for administration.

Results: In Study 1, valbenazine capsules could be opened manually, with the contents easily crushed between spoons. Rapid and complete drug release (>98% in 15 min) was observed in all samples, independent of preparation (whole capsules, crushed contents) or dose (40 mg, 80 mg). For both doses, the average percent released at first and last collection timepoints (10 and 60 min, respectively) was similar for whole versus crushed in each lot. In Study 2, recovery of crushed capsule contents was acceptable within 2 hours of addition to tested foods, buffers, or FeSSGF (recovery range: 92-102%), with minimal degradants detected. In Study 3, acceptable recovery was found when crushed capsule contents were dispersed in hot or cold water and added to a G-tube and a cup rinse was performed (recovery range: 91-97%).

Conclusion: Crushing valbenazine capsule contents did not impact in vitro dissolution performance. Mixing the contents with soft foods or liquids across a broad pH range or delivering them in tap water via G‑tube may be acceptable methods for administering valbenazine to patients who have difficulty swallowing.

To cite this abstract in AMA style:

M. Hebert, A. Mar, R. Moore, A. Bristow, S. Siegert. Crushing valbenazine capsule contents for potential addition to soft foods or administration via G tube [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/crushing-valbenazine-capsule-contents-for-potential-addition-to-soft-foods-or-administration-via-g-tube/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/crushing-valbenazine-capsule-contents-for-potential-addition-to-soft-foods-or-administration-via-g-tube/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley